Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Apr;27A(4):307-11.
doi: 10.1007/BF02630908.

Effect of anticoagulants in vitro on the viability of lymphocytes and content of free fatty acids in plasma

Affiliations

Effect of anticoagulants in vitro on the viability of lymphocytes and content of free fatty acids in plasma

A Klein et al. In Vitro Cell Dev Biol. 1991 Apr.

Abstract

These authors attempted to test the effect of anticoagulants on lymphocytes viability by reproducing the procedure used for lymphocyte isolation for various immunologic tests in which blood specimens are allowed to stay at room temperature for 2 h before lymphocytes are isolated. Blood was obtained with three different anticoagulants i.e. heparin, citrate, and CPDA (citrate, phosphate, dextrose, and adenine). Plasma was lyophilized and extracted with ethanol. Dried ethanol extracts were suspended in medium (RPMI 1640 + 10% fetal bovine serum) and incubated with a lymphocyte cell line (MOLT-4). After 24 h of incubation the viability of cells was examined. The following death rates of the cells were observed: heparin -63 +/- 4.6% (mean +/- SEM), citrate -27 +/- 6.7%, and CPDA 6.2 +/- 0.6% (P less than 0.0005). A significant correlation was found between these results and changes in the concentrations of free fatty acids in the extracts. These results emphasize the importance of choosing the right anticoagulant when the viability of lymphocytes is obligatory.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Natl Cancer Inst. 1986 Jul;77(1):29-31 - PubMed
    1. Circ Res. 1970 May;26(5):545-51 - PubMed
    1. Mol Cell Biol. 1981 Oct;1(10):939-48 - PubMed
    1. J Pharmacol Exp Ther. 1982 Feb;220(2):406-10 - PubMed
    1. Acta Med Scand. 1984;216(1):75-83 - PubMed

LinkOut - more resources